scholarly journals Bullous pemphigoid triggered by COVID ‐19 vaccine. Rapid resolution with corticosteroid therapy

2021 ◽  
Author(s):  
Massimo Dell'Antonia ◽  
Speranza Anedda ◽  
Federica Usai ◽  
Laura Atzori ◽  
Caterina Ferreli
DICP ◽  
1989 ◽  
Vol 23 (1) ◽  
pp. 63-63 ◽  
Author(s):  
Louise Mallet ◽  
James W. Cooper ◽  
Joyce Thomas

Captopril is commonly prescribed to patients with hypertension and congestive heart failure. Adverse dermatological reactions have been reported in about ten percent of patients receiving captopril. This case report describes a 77-year-old white woman who developed bullous pemphigoid associated with the use of captopril. The patient presented with bullous eruptions localized on the palms of both hands about 50 days after captopril 25 mg bid was started. Biopsy report was consistent with bullous pemphigoid. Captopril therapy was discontinued and the lesions healed after oral corticosteroid therapy was initiated.


1998 ◽  
Vol 138 (3) ◽  
pp. 547-548 ◽  
Author(s):  
Yamazaki ◽  
Yokozeki ◽  
Katayama ◽  
Komai ◽  
Hashimoto ◽  
...  

1998 ◽  
Vol 37 (12) ◽  
pp. 940-942 ◽  
Author(s):  
Trevor W. Beer ◽  
Harvey R. Smith ◽  
. Mbbs

1980 ◽  
Vol 116 (2) ◽  
pp. 157a-158
Author(s):  
J. Civatte
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document